OpenAI has released GPT-Rosalind, a large language model fine-tuned specifically for life sciences research, marking the ...

OpenAI’s updated Agents SDK adds sandboxing, configurable memory, and file/tool workflows for safer, stronger enterprise ...

SINGAPORE, SINGAPORE, SINGAPORE, April 17, 2026 /EINPresswire.com/ -- Singapore, April 17, 2026 – In 2026, enterprises ...

Following its recently announced partnership with Novo Nordisk, OpenAI is introducing a new reasoning model, GPT-Rosalind, to ...

OpenAI is releasing a new version of its Codex desktop app today. The latest Codex update adds three key features that expand ...

OpenAI is framing GPT-Rosalind as a tool to compress the timeline from scientific idea to clinical evidence. The company ...

SINGAPORE, SINGAPORE, SINGAPORE, April 17, 2026 /EINPresswire.com/ -- Singapore, April 17, 2026 – The AI landscape in ...

OpenAI has expanded the capabilities of its agent-building toolkit, as agentic AI continues to grow in popularity.

OpenAI Group PBC today announced a major revamp of its artificial intelligence coding tool Codex, giving it a number of new ...

GPT-Rosalind is OpenAI's first domain-specific model, built for drug discovery and life sciences—and it's not for everyone.